London - Results of a British meta-analysis suggest that there is no evidence to support the concept that clinicians should use a combination of biological therapies and chemotherapy instead of the commonly used single-agent chemotherapy regimen for patients with metastatic melanoma, news source MedicalNewsToday.com reports.
Exton, Pa. - Biotech company Isolagen announced recently that injections have been completed in the phase 3 clinical trials evaluating the Isolagen Therapy for the treatment of nasolabial folds, and that trial subjects are now in the follow-up period, PRNewswire reports.
Barrington, Ill. - The National Rosacea Society (NRS) has awarded funding to four new studies aimed at learning more about the causes and management of rosacea.
Cambridge, Mass. - Researchers at Harvard Medical School have identified a population of cells capable of initiating human melanomas, which could be targeted in cases of resistance to systemic therapy, HealthDay News reports.
Chicago - Researchers at the University of Illinois at Chicago (UIC) are taking part in a multicenter trial to determine the safety and effectiveness of Allovectin-7 (Vical) for treating advanced melanoma.
Los Angeles - The findings of a University of Southern California (USC) stem cell research team may lead to new ways to regulate hair and, ultimately, organ regeneration, Newswise.com reports.
However effective Mohs surgery may be, its significant benefits are not inexpensive.
There is growing evidence that vitamin D "protects" us against colorectal, breast and prostate cancers. According to a recent study in patients with multiple primary and primary single melanomas, chronic daily sun exposure may be more beneficial than harmful in that it contributes to a great extent to vitamin D synthesis.
Boston - Any face transplant performed at Brigham and Women's Hospital, based here, will be the culmination of carefully designed consent procedures for both the recipient and the donor's family, says the project's leader.
Special to Dermatology Times - Spurred by consumer complaints, the state of Kansas has restricted the use of Lipodissolve to scientific studies, while the state of Nebraska might ban the procedure.
St. Louis - Facing consumer complaints and investors' exit, lipotherapy chain Fig announced in late 2007 it probably would file for bankruptcy protection.
Patients suffering from atopic dermatitis seem to be at an increased risk of developing malignancies, including lymphoma and cutaneous melanoma, as well as nonmelanoma skin cancers, when compared with patients who do not suffer from the disease, according to a recent large database-controlled study
Early detection of melanoma in older groups, particularly men, has the potential to markedly reduce the death rate of melanoma.
Botulinum neurotoxins are commonly used for a variety of diseases as well as numerous cosmetic interventions. Though effective in each of its uses, the technique of administering the neurotoxin into the skin is by injection, which can be a source of trepidation for the most weathered cosmetic patient. A recent Italian study has proven that botulinum toxin type A can be effectively administered into the skin using pulsed current iontophoresis, giving hope for needle-wary patients.
The skinny on lip cosmetics, milk as a sunburn remedy and eyelash enhancers.
Mohs surgery and topical chemotherapy are among the most effective treatments for certain types of skin cancer, according to David J. Goldberg, M.D. In the very near future, however, photodynamic therapy - now commonly used with good results in Europe - may well become the gold-standard treatment for skin cancers in the United States.
Epidemiological data on the prevalence and degree of cardiovascular morbidity and mortality in patients with psoriasis are contradictory. A team of German researchers recently found that the patients with psoriasis have an increased coronary artery calcification, which precedes myocardial infarction. Thus, psoriasis can be considered as a risk factor for cardiovascular disease.
Results from a series of in vitro studies show a new combination clindamycin/tretinoin product (Zianis, Medicis) may potentially be applied sequentially with benzoyl peroxide without concern about loss of activity from tretinoin degradation.
Conducting a pilot study is key to launching a successful larger research study. In a pilot study, researchers can identify shortcomings like poor adherence and how to address those shortcomings. A timetable for a research study should be established, taking into account the experience and competence of the principal investigator and research team. Data should be reviewed in the initial phase of a research study, when missing information can be more easily retrieved, to minimize the amount of data missing in a study.
According to a Massachusetts General Hospital study recently published in the Annals of Internal Medicine, more than 95 percent of doctors surveyed said impaired or incompetent physicians should always be reported.
Dr. Skin has a Sunbelt-based practice with a heavy emphasis on skin cancer. He has seen thousands of melanomas, some life- threatening, over his 20-year career.
Dermatologists and other physicians who treat Medicare patients have been given a short reprieve from the across-the-board 10.1 percent reimbursement cut that was scheduled for Jan. 1 - and even have received a bit of a raise.
Over the past five years, the words "mesotherapy" and "LipoDissolve" have become a part of mainstream lingo, appearing on billboards, TV and in newspaper ads.
Six easy steps can help you to simplify and reduce expenses for great net income in 2008. Small resolutions can yield big changes.
While nothing has been decided yet, all signs point to the clear fact that significant taxation of assets at death will continue to be an estate planning fact for the foreseeable future.
When the features of the SIMPLE IRA plan and the traditional 401(k) plan are combined into one plan, there are considerable advantages for both employees and business owners.
Bet Shemesh, Israel - In an effort to redirect their business from cosmetics to pharmaceuticals, Sol-Gel Technologies has sold its sunscreen activity to Merck.
